MOST: Eptifibatide, Argatroban Don't Improve on IV Thrombolysis Alone

It’s possible that other classes of antithrombotics may be worth adding to improve reperfusion, but that’s conjecture right now.

Related Keywords

Opeolu Adeoye ,Larry Goldstein ,Andrew Barreto ,International Stroke Conference ,Md University Of Kentucky ,National Institutes Of Health Strokenet ,Md Washington University School Of Medicine ,Washington University School ,Texas Health Science Center ,International Stroke ,National Institutes ,Rankin Scale ,